Experimental Vaccine for Plasmodium Falciparum Malaria
NCT00340431
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
NIH
Sponsor class
Conditions
Plasmodium Falciparum Malaria
Vaccines
Interventions
DRUG:
MSP1(42)-FVO & MSP1(42)-3D7
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)